Publication Name	World Journal of Clinical Cases
Manuscript ID	78092
Country	China

Received	2022-06-07 04:48
Peer-Review Started	2022-06-07 04:51
To Make the First Decision
Return for Revision	2022-06-27 23:36
Revised	2022-06-29 00:54
Second Decision	2022-08-11 02:57
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2022-08-12 21:43
Articles in Press	2022-08-12 21:43
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-08-23 06:50
Publish the Manuscript Online	2022-09-02 06:17

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Letter to the Editor
Article Title	Risk stratification of primary liver cancer
Manuscript Source	Unsolicited Manuscript
All Author List	You-Wen Tan
ORCID	Author(s) ORCID Number You-Wen Tan http://orcid.org/0000-0002-5464-1407
Funding Agency and Grant Number	Funding Agency Grant Number Social Development Project of Jiangsu Province BE2020775 Chinese Federation of Public Health Foundation GWLM202002 Social Development Project of Zhenjiang City SH2020032
Corresponding Author	You-Wen Tan, MD, Chief Doctor, Professor, Department of Hepatology, The Third Hospital of Zhenjiang Affiliated Jiangsu University, No. 300 Daijiamen, Runzhou Distinct, Zhenjiang 212000, Jiangsu Province, China. tyw915@sina.com
Key Words	Risk factors; Model; Primary liver cancer; Hepatocellular carcinoma
Core Tip	PLA prediction models with good clinical validation values have been applied clinically, such as the Toronto hepatocellular carcinoma (HCC) risk index (THRI), REACH-B model, and PAGE-B model. Therefore, the Chinese, together with several research societies, have formulated the “Guideline for stratified screening and surveillance of primary liver cancer (2020 edition).” This guideline outlines PLC screening in at-risk populations, both in hospitals and communities. It is recommended to stratify the at-risk population into four risk levels: low-, intermediate-, high-, and extremely high-risk. This is highly recommended and applied in clinical practice.
Publish Date	2022-09-02 06:17
Citation	Tan YW. Risk stratification of primary liver cancer. World J Clin Cases 2022; 10(26): 9545-9549
URL	https://www.wjgnet.com/2307-8960/full/v10/i26/9545.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i26.9545

Full Article (PDF)	WJCC-10-9545.pdf
Full Article (Word)	WJCC-10-9545.docx
Manuscript File	78092_Auto_Edited-LM.docx
Answering Reviewers	78092-Answering reviewers.pdf
Audio Core Tip	78092-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	78092-Conflict-of-interest statement.pdf
Copyright License Agreement	78092-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	78092-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate	78092-Language certificate.pdf
Peer-review Report	78092-Peer-review(s).pdf
Scientific Misconduct Check	78092-Bing-Wang LL-2.png
Scientific Editor Work List	78092-Scientific editor work list.pdf
CrossCheck Report	78092-CrossCheck report.pdf